These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 2043574)
1. Use of orbital floor steroids in the management of patients with uniocular non-necrotising scleritis. Hakin KN; Ham J; Lightman SL Br J Ophthalmol; 1991 Jun; 75(6):337-9. PubMed ID: 2043574 [TBL] [Abstract][Full Text] [Related]
2. Use of cyclosporin in the management of steroid dependent non-necrotising scleritis. Hakin KN; Ham J; Lightman SL Br J Ophthalmol; 1991 Jun; 75(6):340-1. PubMed ID: 2043575 [TBL] [Abstract][Full Text] [Related]
3. Use of topical steroid therapy in the management of nonnecrotizing anterior scleritis. McMullen M; Kovarik G; Hodge WG Can J Ophthalmol; 1999 Jun; 34(4):217-21. PubMed ID: 10396658 [TBL] [Abstract][Full Text] [Related]
4. [Indication and effect of immunosuppression in patients with scleritis]. Heiligenhaus A; Dück N; Michel D; Hudde T; Koch J; Steuhl KP Klin Monbl Augenheilkd; 2003 Jul; 220(7):471-80. PubMed ID: 12886507 [TBL] [Abstract][Full Text] [Related]
6. Deep intramuscular methylprednisolone treatment of recurrent scleritis. Deokule S; Saeed T; Murray PI Ocul Immunol Inflamm; 2005 Feb; 13(1):67-71. PubMed ID: 15804772 [TBL] [Abstract][Full Text] [Related]
7. An analysis of therapeutic decision for scleritis. Sainz de la Maza M; Jabbur NS; Foster CS Ophthalmology; 1993 Sep; 100(9):1372-6. PubMed ID: 8371926 [TBL] [Abstract][Full Text] [Related]
8. [Transeptal steroids in necrotizing scleritis]. Sainz De La Maza Serra M; Folch Ramos J Arch Soc Esp Oftalmol; 2001 Oct; 76(10):589-92. PubMed ID: 11685675 [TBL] [Abstract][Full Text] [Related]
10. Clinical features and visual outcomes of Japanese patients with scleritis. Keino H; Watanabe T; Taki W; Nakashima C; Okada AA Br J Ophthalmol; 2010 Nov; 94(11):1459-63. PubMed ID: 20576778 [TBL] [Abstract][Full Text] [Related]
12. Scleritis, keratitis, and orbital cellulitis: isolated ocular manifestation of systemic lupus erythematosus. Lin WV; Saumur M; Al-Mohtaseb Z Lupus; 2018 Oct; 27(12):1985-1988. PubMed ID: 30092731 [TBL] [Abstract][Full Text] [Related]
13. Episcleritis and scleritis. White GE Optom Clin; 1991; 1(4):79-87. PubMed ID: 1799838 [TBL] [Abstract][Full Text] [Related]
14. Ocular Pharmacology for Scleritis: Review of Treatment and a Practical Perspective. Stem MS; Todorich B; Faia LJ J Ocul Pharmacol Ther; 2017 May; 33(4):240-246. PubMed ID: 28355124 [TBL] [Abstract][Full Text] [Related]
15. [Episcleritis and scleritis. An overview of modern diagnostic and therapeutic concepts]. Denk PO; Thiel HJ; Zierhut M Klin Monbl Augenheilkd; 1997 Sep; 211(3):140-50. PubMed ID: 9445894 [TBL] [Abstract][Full Text] [Related]
17. Enteric-coated mycophenolate sodium as a corticosteroid-sparing agent for the treatment of autoimmune scleritis. Hwang YS; Chen HC; Chen KJ; Lai CC; Yeung L; Yang KJ; Lin KK; Hsiao CH Cornea; 2011 Mar; 30(3):260-4. PubMed ID: 21099416 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of immunosuppressive agents in the treatment of necrotising scleritis: a retrospective, multicentre study in Korea. Jeon HS; Hyon JY; Kim MK; Chung TY; Yoon KC; Kim JY; Na KS; Kim HJ; Kim TI; Lee JS; Lee HK; Song JS Br J Ophthalmol; 2016 Aug; 100(8):1066-70. PubMed ID: 26598577 [TBL] [Abstract][Full Text] [Related]